Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2021 May 10

PMID 33967614

Authors

Fitri Fareez Ramli

Muhammad Hasif Azizi

Syed Alhafiz Syed Hashim

Affiliations

Soon will be listed here.

Abstract

Sexual dysfunction is a common condition in the opioid substitution therapy (OST) population. We aimed to determine the efficacy and safety of treatment for sexual dysfunction in the OST population. We searched for interventional studies from Medline, PubMed, and Scopus. Three independent authors conducted a risk-of-bias assessment (RoB 2). A total of seven studies (five randomized-controlled trials, two quasi-experimental), including 473 patients with sexual dysfunction, were identified. Among these, three bupropion (n=207), one trazodone (n=75), two rosa Damascena (n=100), and one ginseng (n=91) studies had reported significantly improve various sexual functioning domains in both genders. In a meta-analysis, bupropion significantly increased male sexual function with standardized mean difference of 0.53; 95% confidence interval of 0.19-0.88; P < 0.01; I=0. The adverse effects were minor for all agents, and no significant difference between treatment and placebo groups in randomized-controlled trials. These agents have a promising future as therapy for sexual dysfunction in the OST population. However, given the limited sample size and number of studies, further studies should be conducted to confirm the use of these agents.

References

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Yee A, Loh H, Ong T, Ng C, Sulaiman A . Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men. Am J Mens Health. 2018; 12(5):1705-1718. PMC: 6142124. DOI: 10.1177/1557988318784152. View

Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D . Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab. 2004; 90(1):203-6. DOI: 10.1210/jc.2004-0929. View

Ramli F, Shuid A, Pakri Mohamed R, Tg Abu Bakar Sidik T, Naina Mohamed I . Health-Seeking Behavior for Erectile Dysfunction in Methadone Maintenance Treatment Patients. Int J Environ Res Public Health. 2019; 16(21). PMC: 6862227. DOI: 10.3390/ijerph16214249. View

Sterne J, Savovic J, Page M, Elbers R, Blencowe N, Boutron I . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898. DOI: 10.1136/bmj.l4898. View

Ramli F, Tg Abu Bakar Sidik T, Naina Mohamed I . Sexual Inactivity in Methadone Maintenance Treatment Patients. Int J Environ Res Public Health. 2020; 17(6). PMC: 7142572. DOI: 10.3390/ijerph17061993. View

Fink H, MacDonald R, Rutks I, Wilt T . Trazodone for erectile dysfunction: a systematic review and meta-analysis. BJU Int. 2003; 92(4):441-6. DOI: 10.1046/j.1464-410x.2003.04358.x. View

Safarinejad M . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU Int. 2010; 106(6):840-7. DOI: 10.1111/j.1464-410X.2009.09154.x. View

10.

Rhodin A, Stridsberg M, Gordh T . Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain. 2010; 26(5):374-80. DOI: 10.1097/AJP.0b013e3181d1059d. View

11.

Murphy L, Lee T . Ginseng, sex behavior, and nitric oxide. Ann N Y Acad Sci. 2002; 962:372-7. DOI: 10.1111/j.1749-6632.2002.tb04081.x. View

12.

Ramli F . Pharmacogenomics biomarkers for personalized methadone maintenance treatment: The mechanism and its potential use. Bosn J Basic Med Sci. 2020; 21(2):145-154. PMC: 7982063. DOI: 10.17305/bjbms.2020.4897. View

13.

Farnia V, Alikhani M, Ebrahimi A, Golshani S, Sadeghi Bahmani D, Brand S . Ginseng treatment improves the sexual side effects of methadone maintenance treatment. Psychiatry Res. 2019; 276:142-150. DOI: 10.1016/j.psychres.2019.05.004. View

14.

Farnia V, Tatari F, Alikhani M, Shakeri J, Taghizadeh M, Karbasizadeh H . Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy-results from a double-blind, randomized, placebo-controlled clinical trial. Drug Alcohol Depend. 2017; 176:117-125. DOI: 10.1016/j.drugalcdep.2017.02.008. View

15.

Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F . Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010; 57(5):804-14. DOI: 10.1016/j.eururo.2010.02.020. View

16.

Krakowsky Y, Grober E . A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada. Can Urol Assoc J. 2018; 12(6):211-216. PMC: 5994984. DOI: 10.5489/cuaj.4907. View

17.

Choi Y, Park C, Jang J, Kim S, Jeon H, Kim W . Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: a multicenter, placebo-controlled, double-blind clinical study. Int J Impot Res. 2012; 25(2):45-50. DOI: 10.1038/ijir.2012.45. View

18.

Farnia V, Hojatitabar S, Shakeri J, Rezaei M, Yazdchi K, Bajoghli H . Adjuvant Rosa Damascena has a Small Effect on SSRI-induced Sexual Dysfunction in Female Patients Suffering from MDD. Pharmacopsychiatry. 2015; 48(4-5):156-63. DOI: 10.1055/s-0035-1554712. View

19.

Stahl S, Pradko J, Haight B, Modell J, Rockett C, Learned-Coughlin S . A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. Prim Care Companion J Clin Psychiatry. 2004; 6(4):159-166. PMC: 514842. DOI: 10.4088/pcc.v06n0403. View

20.

Brown R, Balousek S, Mundt M, Fleming M . Methadone maintenance and male sexual dysfunction. J Addict Dis. 2005; 24(2):91-106. DOI: 10.1300/J069v24n02_08. View